Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Raman Spectroscopy Compared to Flow Cytometry as a Method for Assessing Measurable Residual Disease in Patients With Acute Lymphoblastic Leukemia

NCT06291428 is registered in ClinicalTrials.gov with Hospital Regional de Alta Especialidad del Bajio as lead sponsor.

NCT NCT06291428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06291428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Raman Spectroscopy Compared to Flow Cytometry as a Method for Assessing Measurable Residual Disease in Patients With Acute Lymphoblastic Leukemia
Lead sponsor
Hospital Regional de Alta Especialidad del Bajio
Phase
Observational
Overall status
Recruiting
Start date
October 15, 2024
Completion date
December 30, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia